Your browser doesn't support javascript.
loading
JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors.
Dusa, Alexandra; Mouton, Céline; Pecquet, Christian; Herman, Murielle; Constantinescu, Stefan N.
Affiliation
  • Dusa A; Ludwig Institute for Cancer Research Ltd., Brussels, Belgium.
PLoS One ; 5(6): e11157, 2010 Jun 16.
Article in En | MEDLINE | ID: mdl-20585391
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinase Inhibitors / Janus Kinase 2 Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2010 Document type: Article Affiliation country: Belgium Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinase Inhibitors / Janus Kinase 2 Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2010 Document type: Article Affiliation country: Belgium Country of publication: United States